IGFBP1 and leukemia: For instance, leukemia has been reported to increase the production of the adipokine IGFBP1, reduce incretin activity, short chain fatty acids, and 5-hydroxytryptamine production, causes intestinal flora imbalances to promote insulin resistance, the systemic destruction of glucose metabolism, and hijacking host glucose in order to promote tumor growth [37].